Accelerating CNS clinical trials
Location: Ireland
Total raised: $12.75M
Investors 5
| Date | Name | Website |
| - | Techstart ... | techstart.... |
| - | SV Health ... | svhealthin... |
| - | Life Arc V... | lifearcven... |
| 13.05.2021 | Co-FundNI | cofundni.c... |
| - | Clarendon ... | clarendon-... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.07.2025 | - | $4.4M | Angel CoFu... |
| 05.05.2021 | - | $8.35M | Dementia D... |
Mentions in press and media 21
| Date | Title | Description |
| 08.07.2025 | Cumulus raises £3.25M to advance neuroscience clinical trials through at-home EEG-tech | Irish startup Cumulus Neuroscience has raised £3.25 million for its NeuLogic platform. The startup is focused on advancing neuroscience clinical trials and patient care through improved data and AI. The NeuLogiq Platform was purpose-built i... |
| 11.07.2024 | Cumulus Neuroscience to Join Bio-Hermes 2 Study with Funding from the Innovate UK Small Business Research Initiative (SBRI) Dementia Mission Project | Funded by a nearly £1.2M (~$1.5M USD) award, this research will enable ongoing validation of AccelADx™, a breakthrough screening test for early detection of Alzheimer's dementia. BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 11, 2024... |
| 11.06.2024 | Cumulus Neuroscience to Partner with The Digital Medicine Society (DiMe) to Drive Adoption of Digital Endpoints in Clinical Trials | Cumulus to participate in The Digital Health Measurement Collaborative Community (DATAcc) by DiMe project – Building the Business Case for Digital Endpoints – to establish industry benchmarks for evaluating return on investment when utilize... |
| 27.03.2024 | Cumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia | Funded by a nearly £1M (~$1.25M USD) grant, this research will enable development and validation of an artificial intelligence (AI) diagnostic tool that improves the accuracy of blood biomarkers. Cumulus Neuroscience today announced receipt... |
| 22.03.2024 | 35% of Northern Ireland's funding deals went to women-led startups last year | 65 per cent of Northern Ireland's 72 funding deals last year went to startups with all-male executive teams, according to Catalyst’s Deal Tracker. Of all companies who received funding, 35 per cent had at least one female executive whilst z... |
| 15.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx™ Electroencephalogram (EEG) Study for Early Detection of Alzheimer’s Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer’s Dementia BELFAST, Northern Ireland and CAMBRIDGE, Mass.—March 14, 2024— Cumulus Neuroscience (Cumulus; The Company), a global digital health company focu... |
| 14.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer's Dementia. Cumulus Neuroscience today announced the enrollment of the first patient in a major research collaboration with the Universities of Bath and Bri... |
| 25.01.2024 | Six new investments, portfolio progress and an expanding investment team | Clare Terlouw, Head of LifeArc Ventures, said: “Our portfolio of investments expanded during the year and despite challenging financing conditions in the sector we were pleased to invest in six new companies and to continue to support our e... |
| 25.10.2023 | Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting | Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, presented data at the Clinical Trials on Alzheimer’s Disease (CTAD) Annua... |
| 20.10.2023 | 3 LifeArc Ventures’ portfolio companies celebrated in new report on most innovative life science businesses in UK | With the UK setting its sights on becoming a global life sciences superpower, it has created an environment where scientists are able to push the boundaries of research to create breakthrough science. Many companies and start-ups have rise... |
Show more